Litcius/Paper detail

Phase 1 Study of the Combination of Escalated Total Marrow Irradiation Using Helical Tomotherapy and Fixed High-Dose Melphalan (140 mg/m²) Followed by Autologous Stem Cell Transplantation at First Relapse in Multiple Myeloma

Axel Cailleteau, P. Maingon, Sylvain Choquet, R. Bourdais, D. Antoni, Bruno Lioure, Cyrille Hulin, S. Batard, C. Llagostera, Valentine Guimas, Cyrille Touzeau, Philippe Moreau, Marc-André Mahé, S. Supiot

2022International Journal of Radiation Oncology*Biology*Physics11 citationsDOI

Topics & Concepts

TomotherapyMelphalanMedicineStem cellTransplantationNuclear medicineOncologyRadiation therapySurgeryBiologyGeneticsMultiple Myeloma Research and TreatmentsHematopoietic Stem Cell TransplantationOral health in cancer treatment
Phase 1 Study of the Combination of Escalated Total Marrow Irradiation Using Helical Tomotherapy and Fixed High-Dose Melphalan (140 mg/m²) Followed by Autologous Stem Cell Transplantation at First Relapse in Multiple Myeloma | Litcius